Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

fool.com - Seena Hassouna - ENAVATE's Zenas Bio Pharma add Is a Footnote - The Obexelimab Pipeline Is What to Watch
ENAVATE's Zenas Bio Pharma add Is a Footnote - The Obexelimab Pipeline Is What to Watch
The Motley Fool

On February 17, 2026, ENAVATE Sciences GP, LLC disclosed a buy of 157,800 shares of Zenas BioPharma (ZBIO 4.58%), an estimated $5.19 million trade based on quarterly average pricing. ENAVATE Sciences added 157,800 shares of Zenas BioPharma, an…

marketbeat.com - JPMorgan Chase & Co. Trims Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
JPMorgan Chase & Co. Trims Stock Position in NewAmsterdam Pharma Company N.V. $NAMS
MarketBeat

JPMorgan Chase & Co. cut its holdings in shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS - Free Report) by 10.7% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned…

mediabistro.com - Media News - New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
New to The Street Announces Broadcast of Show #739 on Bloomberg Television Across the U.S. at 6:30 PM EST
Mediabistro

Featured Companies Include FreeCast (NASDAQ:CAST), KLED.ai, Lantern Pharma (NASDAQ:LTRN), and BlackBarn Restaurant New to The Street, one of the longest-running U.S. and international sponsored television brands, proudly announces the nationwide…

businessinsider.com - Arielle Pardes - Meet Superpower, the Silicon Valley startup that wants to make you hotter, smarter, and healthier
Meet Superpower, the Silicon Valley startup that wants to make you hotter, smarter, and healthier
Business Insider

For the techno-optimized, nearly everything in life can be improved with the help of engineering. Bots can auto-swipe on Tinder and flirt with matches on your behalf. AI avatars can attend Zoom meetings so that you don't have to. Almost nothing is…

fool.com - Adria Cimino - Should You Buy Eli Lilly Stock Before April 10?
Should You Buy Eli Lilly Stock Before April 10?
The Motley Fool

Eli Lilly (LLY 1.29%) has climbed in recent years as growth investors piled into the stock. Generally, big pharmaceutical companies aren't known for delivering enormous levels of growth and instead may gain at a more measured pace. Lilly has stood…

nationalpost.com - Bloomberg News - India drugmakers to sell Ozempic copy for $14 a month as Novo patent expires
India drugmakers to sell Ozempic copy for $14 a month as Novo patent expires
National Post

Indian drugmakers seized on the patent expiry for Novo Nordisk A/S's blockbuster weight-loss and diabetes medication to roll out cut-price generic versions in a nation with the third-largest overweight population. Natco Pharma Ltd. plans to make an…

dynamitenews.com - Sona Saini - Obesity Crisis in India: Low Awareness Limits Use of GLP-1 Treatments | Dynamite News
Obesity Crisis in India: Low Awareness Limits Use of GLP-1 Treatments | Dynamite News
News: Today's News Headlines & Daily Updates from Sports, Movies, Politics, Business | Dynamite News

India is facing a growing obesity crisis, with nearly 250 million affected, yet less than 0.1% are using GLP-1 treatments. Experts highlight lack of awareness as the biggest challenge rather than cost. Drugs like semaglutide are gaining attention…

thehindubusinessline.com - Generic versions of Novo Nordisk's semaglutide begin to flow, priced 50-80% lower than the innovator
Generic versions of Novo Nordisk's semaglutide begin to flow, priced 50-80% lower than the innovator
BusinessLine

The trickle has become a flow of generic semaglutide – the active ingredient in Novo Nordisk's Wegovy (for obesity) and Ozempic (for Type II diabetes). At least seven major drugmakers announced the launch of their generic versions of…

rappler.com - Walden Bello - [Opinion] The existential crisis of mainstream economics
[Opinion] The existential crisis of mainstream economics
RAPPLER

Had I not read Angus Deaton's Economics in America: An Immigrant Economist Explores the Land of Inequality (Princeton University Press 2023), I would not have learned that one of the most devastating blows to the economics profession was delivered…

theatlantic.com - Helen Lewis - The Death of Millennial Feminism
The Death of Millennial Feminism
The Atlantic

Lindy West is the most successful feminist writer of her (and my) generation. In her pomp at Jezebel, she mastered both viral takedowns—sorry, Love Actually —and confessional writing. She embraced adjectives that were meant to demean…

marketbeat.com - Schrodinger Conference: SDGR Targets Hosted Shift, Platform Adoption, EBITDA Profitability in 3 Years
Schrodinger Conference: SDGR Targets Hosted Shift, Platform Adoption, EBITDA Profitability in 3 Years
MarketBeat

3 Momentum Stocks That Could Soar Post-Market Volatility Schrodinger NASDAQ: SDGR executives outlined a strategy focused on expanding adoption of its computational chemistry platform, accelerating a shift to hosted software delivery, and partnering…

marketbeat.com - Hudson Bay Capital Management LP Acquires 105,000 Shares of Teva Pharmaceutical Industries Ltd. $TEVA
Hudson Bay Capital Management LP Acquires 105,000 Shares of Teva Pharmaceutical Industries Ltd. $TEVA
MarketBeat

Hudson Bay Capital Management LP grew its stake in Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Free Report) by 87.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The…

thehindubusinessline.com - Navin Fluorine: What Should You Do?
Navin Fluorine: What Should You Do?
BusinessLine

Navin Fluorine's growth prospects were initially highlighted with our accumulate call in November 2023 when the stock was trading at ₹3,609 and followed up with a hold call in May 2025 when it was trading at ₹4,242. Our positive…

marketbeat.com - CWA Asset Management Group LLC Increases Holdings in Novartis AG $NVS
CWA Asset Management Group LLC Increases Holdings in Novartis AG $NVS
MarketBeat

CWA Asset Management Group LLC raised its holdings in shares of Novartis AG (NYSE:NVS - Free Report) by 151.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned…

marketbeat.com - Great Oak Capital Partners LLC Has $1.52 Million Stock Position in Johnson & Johnson $JNJ
Great Oak Capital Partners LLC Has $1.52 Million Stock Position in Johnson & Johnson $JNJ
MarketBeat

Great Oak Capital Partners LLC boosted its holdings in Johnson & Johnson (NYSE:JNJ - Free Report) by 336.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,322…

Receive a Daily briefing on Pharma Industry News

Get Started